DENYES NANCY 4
4 · aTYR PHARMA INC · Filed Jun 6, 2024
Insider Transaction Report
Form 4
aTYR PHARMA INCATYR
DENYES NANCY
General Counsel
Transactions
- Purchase
Common Stock
2024-06-05$1.86/sh+5,000$9,276→ 22,267 total
Footnotes (2)
- [F1]Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.835 to $1.87 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 2,500 shares acquired on May 15, 2024 under the Company's 2015 Employee Purchase Plan.